全文获取类型
收费全文 | 591篇 |
免费 | 11篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 8篇 |
妇产科学 | 2篇 |
基础医学 | 16篇 |
临床医学 | 44篇 |
内科学 | 63篇 |
神经病学 | 13篇 |
特种医学 | 7篇 |
外国民族医学 | 1篇 |
外科学 | 327篇 |
综合类 | 88篇 |
预防医学 | 18篇 |
眼科学 | 1篇 |
药学 | 17篇 |
中国医学 | 2篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 5篇 |
2022年 | 2篇 |
2021年 | 9篇 |
2020年 | 4篇 |
2019年 | 35篇 |
2018年 | 33篇 |
2017年 | 31篇 |
2016年 | 5篇 |
2015年 | 16篇 |
2014年 | 48篇 |
2013年 | 34篇 |
2012年 | 14篇 |
2011年 | 34篇 |
2010年 | 35篇 |
2009年 | 47篇 |
2008年 | 52篇 |
2007年 | 18篇 |
2006年 | 23篇 |
2005年 | 41篇 |
2004年 | 20篇 |
2003年 | 24篇 |
2002年 | 8篇 |
2001年 | 11篇 |
2000年 | 13篇 |
1999年 | 11篇 |
1998年 | 3篇 |
1997年 | 5篇 |
1996年 | 4篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1985年 | 1篇 |
1984年 | 1篇 |
排序方式: 共有609条查询结果,搜索用时 15 毫秒
61.
62.
Nelson DA Nelson KT Miller MW Dupe R Chahwala SB Kennedy A Chander C Fossum TW 《The Journal of extra-corporeal technology》2008,40(2):116-122
Heparin-induced thrombocytopenia can be a life-threatening sequel to conventional use of unfractionated heparin in cardiopulmonary bypass (CPB). This study evaluated the pharmacokinetic/pharmacodynamic (PK/PD) and efficacy profile of a novel direct thrombin inhibitor, TGN 255, during cardiac surgery in dogs. Point-of-care coagulation monitoring was also compared against the plasma concentrations of TRI 50c, the active metabolite of TGN 255. The study was conducted in three phases using 10 animals: phase 1 was a dose-ranging study in conscious animals (n = 6), phase 2 was a similar but terminal dose-ranging study in dogs undergoing CPB (n = 6), and phase 3 was with animals undergoing simulated mitral valve repair (terminal) using optimal TGN 255 dose regimens derived from phases I and II (n = 4). During the study, PD markers and drug plasma levels were determined. In addition, determinations of hematologic markers and blood loss were undertaken. Phase 1 studies showed that a high-dose regimen of a 5-mg/kg bolus and infusion of 20 mg/kg/h elevated PD markers in conscious animals, at which time there were no measured effects on platelet or red blood cell counts, and the mean plasma concentration of TRI 50C was 20.6 microg/mL. In the phase 2 CPB dose-ranging study, this dosing regimen significantly elevated all the PD markers and produced hemorrhagic and paradoxical thrombogenic effects. In the phase 3 surgical study, a lower TGN 255 dose regimen of a 2.5-mg/kg bolus plus 10 mg/kg/h produced anticoagulation, elevated PD markers, and produced minimal post-operative blood loss in the animals. Plasma levels of TRI 50C trended well with the conventional point-of-care coagulation monitoring. TGN 255 provided effective anticoagulation in a canine CPB procedure, enabling successful completion with minimal blood loss. These findings support further evaluation of TGN 255 as an anticoagulant for CPB. 相似文献
63.
64.
65.
66.
67.
68.
Ohye RG Gaynor JW Ghanayem NS Goldberg CS Laussen PC Frommelt PC Newburger JW Pearson GD Tabbutt S Wernovsky G Wruck LM Atz AM Colan SD Jaggers J McCrindle BW Prakash A Puchalski MD Sleeper LA Stylianou MP Mahony L;Pediatric Heart Network Investigators 《The Journal of thoracic and cardiovascular surgery》2008,136(4):968-975
69.